AIB Acquisition Corporation Completes $86.25 Million IPO Including Full Exercise of Over-Allotment Option

The Company announces an expansion of product offerings online and in over 840 GNC Holdings, LLC (GNC) retail locations nationwide.

CHARLOTTE, NC, March 3, 2022 /PRNewswire-PRWeb/ — cbdMD, Inc. (NYSE American: YCBD, YCBDpA), (the “Company”), one of the world’s leading and most trusted and recognized CBD health and wellness companies, has announced an expansion of its product offering online and at over 840 GNC Holdings, LLC (GNC) retail locations nationwide.

cbdMD entered into a partnership with GNC for the first time Aug 2020, and included a launch of three current SKUs in fewer than 100 retail stores across the country. Based on consumer receptivity and overall purchasing performance, cbdMD is adding an additional 11 SKUs available online and in over 840 retail stores across the country. The product offering expansion includes a variety of ingestible products: functional CBD chewing gums, sleep aids, softgels and tinctures. Current products will continue to be available both online and in store. Along with the product and store expansion, cbdMD is acquiring a more visible presence in both online and retail stores, positioning products alongside other everyday health and wellness options for consumers.

“It is exciting to expand our partnership with GNC to bring consumers a full range of product offerings for everyday wellness choices. We are proud to offer GNC customers a variety of premium CBD and wellness products, all designed to complement their daily routine. We believe this is just the next step in bringing greater awareness and accessibility of CBD products to millions of people across the country,” he said Pancho Manuel EVP of Sales for cbdMD, Inc.

More information about cbdMD, Inc. at GNC can be found here.

About cbdMD, Inc.
cbdMD, Inc. is one of the leading and most trusted and recognized cannabidiol (CBD) brands with a comprehensive line of USA made, THC-free1 CBD products. The cbdMD brand currently features over 130 SKUs of premium quality CBD products including CBD Tinctures, CBD Gummies, CBD Topics, CBD Capsules, CBD Bath Bombs, CBD Bath Salts, CBD Sleep Aids, CBD Drink Mixes and Full Spectrum CBD options. Our Paw CBD branded pet products include over 45 SKUs of veterinarian-formulated products including tinctures, chews and topicals in varying strengths, and our cbdMD Botanicals branded beauty and skincare products include 15 SKUs including facial oil and serum, toners and moisturizers, Face masks, scrubs and body care. To learn more about cbdMD and their comprehensive line of USA-grown, THC-free1 CBD oil and full-spectrum products, please visit, follow cbdMD on Instagram and Facebook, or visit any of the 6,000 retail stores stock cbdMD products.

The story goes on

Forward-Looking Statements
This press release contains certain forward-looking statements that are based on current expectations and involve certain risks and uncertainties within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 ”should” ”may” ”intend” ”anticipate” ”believes” ”estimates” ”forecasts” ”forecast” ”expects”, ”plans” and ”proposes”. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond our control and are difficult to predict and could cause actual results to differ materially from those expressed or projected in the forward-looking statements, including but not limited to, statements regarding the expansion of the consumer CBD products market, our ability to increase our market share, the availability of the Amazon platform for our CBD products, our a our ability to grow our business and our significantly increase revenue, our ability to leverage our brand partnerships and sponsorships effectively, our ability to compete effectively in our marketplace, our ability to meet our net sales forecast and our ability to report profitable business in the future. You are urged to carefully review and consider all cautionary statements and other disclosures, including statements made under the heading “Risk Factors” in cbdMD, Inc.’s Annual Report on Form 10-K for the past fiscal year September 30, 2021 as filed with the Securities and Exchange Commission (the “SEC”) and our other filings with the SEC. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, many of which are generally beyond cbdMD, Inc.’s control and are difficult to predict. cbdMD, Inc. undertakes no obligation to update any forward-looking statements, except as required by law. The information that appears on our websites and our social media platforms, including but not limited to Instagram and Facebook, is not part of this press release.
1 THC-free is defined as below the limit of detection using validated scientific methods.

Robert Pettway Director, Paid Media
[email protected]
(423) 503-5225

John Weston
Investor Relations Director
[email protected]
(704) 249-9515

media contact

John WestoncbdMD, 704-445-3064, [email protected]